Christina G. Rivera, PharmD

Mayo Clinic

Disclosure(s): Gilead: Grant/Research Support, Honoraria; Insmed: Honoraria

Poster(s):

• 475 - Does Metabolite Matter? Defining Target Itraconazole and Hydroxy-itraconazole Serum Levels for Blastomycosis
  Thursday, October 20, 2022

  12:15 PM – 1:30 PM US ET

• 627 - Too Much of a Good Thing? The Clinical Effects of Very High Serum Posaconazole Levels
  Thursday, October 20, 2022

  12:15 PM – 1:30 PM US ET

• 1752 - Impact of a multifaceted, outpatient antimicrobial stewardship intervention bundle on unnecessary antimicrobial prescribing in upper respiratory tract infections (URI)
  Saturday, October 22, 2022

  12:15 PM – 1:30 PM US ET